Drug Profile
BVF 068
Alternative Names: BVF-068Latest Information Update: 10 Mar 2010
Price :
$50
*
At a glance
- Originator Pharma Pass II LLC
- Developer Biovail Corporation
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued CNS disorders
Most Recent Events
- 07 Nov 2007 Preclinical trials in CNS disorders in USA (unspecified route)